skip to content
Preoperative (Neoadjuvant) Chemotherapy Preview this item
ClosePreview this item
Checking...

Preoperative (Neoadjuvant) Chemotherapy

Author: Joseph Ragaz; Pierre R Band; James H Goldie
Publisher: Berlin, Heidelberg : Springer Berlin Heidelberg, 1986.
Series: Recent Results in Cancer Research, 103; Recent results in cancer research, 103.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Database:WorldCat
Summary:
Despite recent advances in adjuvant therapies of cancer, the regi mens of postoperative adjuvant chemotherapy treatment which are presently available fail to cure the majority of cancer patients. Pre operative (neoadjuvant) chemotherapy represents a new approach in drug scheduling, based on sound theoretical, pharmacokinetic, and experimental principles. The preoperative timing of chemotherapy before definitive sur  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Additional Physical Format: Print version:
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Joseph Ragaz; Pierre R Band; James H Goldie
ISBN: 9783642826719 3642826717 9783642826733 3642826733
OCLC Number: 858931023
Description: 1 online resource.
Contents: Clinical and Scientific Considerations in Preoperative (Neoadjuvant) Chemotherapy --
Experimental Adjuvant Chemotherapy: An Overview --
Theoretical Considerations Regarding the Early Use of Adjuvant Chemotherapy --
Experimental Preoperative Chemotherapy --
Implications of Certain Cell Kinetic and Biological Parameters for Preoperative Chemotherapy --
Adjuvant Therapy for Breast Cancer: A Brief Overview of the NSABP Experience and Some Thoughts on Neoadjuvant Chemotherapy --
Factors Affecting the Development of Permanent Drug Resistance and Its Impact upon Neoadjuvant Chemotherapy --
Impact of Preoperative Chemotherapy for the Surgeon --
Preoperative (Neoadjuvant) Chemotherapy for Breast Cancer: Outline of the British Columbia Trial --
Perioperative Adjuvant Chemotherapy of Breast Cancer: The Scandinavian Experience --
Perioperative and Conventionally Timed Chemotherapy in Operable Breast Cancer: The Ludwig Breast Cancer Study V --
Neoadjuvant Chemotherapy in the Conservative Management of Breast Cancer: Study of 143 Patients --
Preliminary Results of Preoperative Chemotherapy with a Combination of Platinum-Bleomycin Administered in 5-Day Cycles in Carcinoma of the Bronchus --
Impact of Primary Site of Stage III and IV Squamous Cell Carcinomas of the Head and Neck on 7-Year Survival Figures Following Initial Non-Cisplatin-Containing Combination Chemotherapy --
Chemotherapy with or Without Anticoagulation as Initial Management of Patients with Operable Colorectal Cancer: A Prospective Study with at Least 5Years Follow-up --
Preoperative Chemotherapy for Gastric Cancer: A Prospective Study with at Least 1 Year Follow-up --
Neoadjuvant Chemotherapy for Osteogenic Sarcoma: A Model for the Treatment of Other Highly Malignant Neoplasms --
Summary of Preoperative (Neoadjuvant) Chemotherapy.
Series Title: Recent Results in Cancer Research, 103; Recent results in cancer research, 103.
Responsibility: edited by Joseph Ragaz, Pierre R. Band, James H. Goldie.

Abstract:

Despite recent advances in adjuvant therapies of cancer, the regi mens of postoperative adjuvant chemotherapy treatment which are presently available fail to cure the majority of cancer patients. Pre operative (neoadjuvant) chemotherapy represents a new approach in drug scheduling, based on sound theoretical, pharmacokinetic, and experimental principles. The preoperative timing of chemotherapy before definitive sur gery is not a minor change in the therapy of cancer. To be successful, large numbers of practitioners and their patients must participate. Substantial alterations of many aspects of the present management of cancer will have to follow. Therefore, before such therapy can be fully and routinely implemented, results of the novel treatment and its rationale have to be carefully evaluated. In preoperative treatment, other features will likely gain impor tance. For the first time, clinicians have a chance to follow the in vivo response of the tumor exposed to preoperative chemotherapy. The subsequent histological assessment of the tumor sample may likely become an important prognostic guide, permitting more re fined individual approaches to the planning of postoperative adju vant treatment. The value of such a treatment strategy can already be appreciated in the clinical setting, as seen from the therapy of osteosarcoma. Furthermore, preoperative chemotherapy might render previously inoperable tumors operable and hence resectable with a curative intention. The preoperative reduction of tumor bulk may also effectively decrease the need for more radical operations, permitting a more uniform adoption of conservative surgery.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.

Similar Items

Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/858931023> # Preoperative (Neoadjuvant) Chemotherapy
    a schema:MediaObject, schema:CreativeWork, schema:Book ;
   library:oclcnum "858931023" ;
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/gw> ;
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/355964200#Place/berlin_heidelberg> ; # Berlin, Heidelberg
   schema:about <http://id.worldcat.org/fast/976610> ; # Internal medicine
   schema:about <http://id.worldcat.org/fast/1014893> ; # Medicine
   schema:about <http://id.worldcat.org/fast/1045739> ; # Oncology
   schema:about <http://dewey.info/class/616.994/e23/> ;
   schema:about <http://id.worldcat.org/fast/1153364> ; # Toxicology
   schema:about <http://id.worldcat.org/fast/1139351> ; # Surgery
   schema:bookFormat schema:EBook ;
   schema:contributor <http://experiment.worldcat.org/entity/work/data/355964200#Person/band_pierre_r> ; # Pierre R. Band
   schema:contributor <http://experiment.worldcat.org/entity/work/data/355964200#Person/goldie_james_h> ; # James H. Goldie
   schema:creator <http://experiment.worldcat.org/entity/work/data/355964200#Person/ragaz_joseph> ; # Joseph Ragaz
   schema:datePublished "1986" ;
   schema:description "Despite recent advances in adjuvant therapies of cancer, the regi mens of postoperative adjuvant chemotherapy treatment which are presently available fail to cure the majority of cancer patients. Pre operative (neoadjuvant) chemotherapy represents a new approach in drug scheduling, based on sound theoretical, pharmacokinetic, and experimental principles. The preoperative timing of chemotherapy before definitive sur gery is not a minor change in the therapy of cancer. To be successful, large numbers of practitioners and their patients must participate. Substantial alterations of many aspects of the present management of cancer will have to follow. Therefore, before such therapy can be fully and routinely implemented, results of the novel treatment and its rationale have to be carefully evaluated. In preoperative treatment, other features will likely gain impor tance. For the first time, clinicians have a chance to follow the in vivo response of the tumor exposed to preoperative chemotherapy. The subsequent histological assessment of the tumor sample may likely become an important prognostic guide, permitting more re fined individual approaches to the planning of postoperative adju vant treatment. The value of such a treatment strategy can already be appreciated in the clinical setting, as seen from the therapy of osteosarcoma. Furthermore, preoperative chemotherapy might render previously inoperable tumors operable and hence resectable with a curative intention. The preoperative reduction of tumor bulk may also effectively decrease the need for more radical operations, permitting a more uniform adoption of conservative surgery."@en ;
   schema:description "Clinical and Scientific Considerations in Preoperative (Neoadjuvant) Chemotherapy -- Experimental Adjuvant Chemotherapy: An Overview -- Theoretical Considerations Regarding the Early Use of Adjuvant Chemotherapy -- Experimental Preoperative Chemotherapy -- Implications of Certain Cell Kinetic and Biological Parameters for Preoperative Chemotherapy -- Adjuvant Therapy for Breast Cancer: A Brief Overview of the NSABP Experience and Some Thoughts on Neoadjuvant Chemotherapy -- Factors Affecting the Development of Permanent Drug Resistance and Its Impact upon Neoadjuvant Chemotherapy -- Impact of Preoperative Chemotherapy for the Surgeon -- Preoperative (Neoadjuvant) Chemotherapy for Breast Cancer: Outline of the British Columbia Trial -- Perioperative Adjuvant Chemotherapy of Breast Cancer: The Scandinavian Experience -- Perioperative and Conventionally Timed Chemotherapy in Operable Breast Cancer: The Ludwig Breast Cancer Study V -- Neoadjuvant Chemotherapy in the Conservative Management of Breast Cancer: Study of 143 Patients -- Preliminary Results of Preoperative Chemotherapy with a Combination of Platinum-Bleomycin Administered in 5-Day Cycles in Carcinoma of the Bronchus -- Impact of Primary Site of Stage III and IV Squamous Cell Carcinomas of the Head and Neck on 7-Year Survival Figures Following Initial Non-Cisplatin-Containing Combination Chemotherapy -- Chemotherapy with or Without Anticoagulation as Initial Management of Patients with Operable Colorectal Cancer: A Prospective Study with at Least 5Years Follow-up -- Preoperative Chemotherapy for Gastric Cancer: A Prospective Study with at Least 1 Year Follow-up -- Neoadjuvant Chemotherapy for Osteogenic Sarcoma: A Model for the Treatment of Other Highly Malignant Neoplasms -- Summary of Preoperative (Neoadjuvant) Chemotherapy."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/355964200> ;
   schema:genre "Electronic books"@en ;
   schema:inLanguage "en" ;
   schema:isPartOf <http://worldcat.org/issn/0080-0015> ; # Recent results in cancer research ;
   schema:isSimilarTo <http://worldcat.org/entity/work/data/355964200#CreativeWork/> ;
   schema:name "Preoperative (Neoadjuvant) Chemotherapy"@en ;
   schema:productID "858931023" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/858931023#PublicationEvent/berlin_heidelberg_springer_berlin_heidelberg_1986> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/355964200#Agent/springer_berlin_heidelberg> ; # Springer Berlin Heidelberg
   schema:url <http://dx.doi.org/10.1007/978-3-642-82671-9> ;
   schema:url <http://link.springer.com/10.1007/978-3-642-82671-9> ;
   schema:url <http://public.eblib.com/choice/publicfullrecord.aspx?p=3095499> ;
   schema:workExample <http://dx.doi.org/10.1007/978-3-642-82671-9> ;
   schema:workExample <http://worldcat.org/isbn/9783642826719> ;
   schema:workExample <http://worldcat.org/isbn/9783642826733> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/858931023> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/355964200#Agent/springer_berlin_heidelberg> # Springer Berlin Heidelberg
    a bgn:Agent ;
   schema:name "Springer Berlin Heidelberg" ;
    .

<http://experiment.worldcat.org/entity/work/data/355964200#Person/band_pierre_r> # Pierre R. Band
    a schema:Person ;
   schema:familyName "Band" ;
   schema:givenName "Pierre R." ;
   schema:name "Pierre R. Band" ;
    .

<http://experiment.worldcat.org/entity/work/data/355964200#Person/goldie_james_h> # James H. Goldie
    a schema:Person ;
   schema:familyName "Goldie" ;
   schema:givenName "James H." ;
   schema:name "James H. Goldie" ;
    .

<http://experiment.worldcat.org/entity/work/data/355964200#Person/ragaz_joseph> # Joseph Ragaz
    a schema:Person ;
   schema:familyName "Ragaz" ;
   schema:givenName "Joseph" ;
   schema:name "Joseph Ragaz" ;
    .

<http://experiment.worldcat.org/entity/work/data/355964200#Place/berlin_heidelberg> # Berlin, Heidelberg
    a schema:Place ;
   schema:name "Berlin, Heidelberg" ;
    .

<http://id.worldcat.org/fast/1014893> # Medicine
    a schema:Intangible ;
   schema:name "Medicine"@en ;
    .

<http://id.worldcat.org/fast/1045739> # Oncology
    a schema:Intangible ;
   schema:name "Oncology"@en ;
    .

<http://id.worldcat.org/fast/1139351> # Surgery
    a schema:Intangible ;
   schema:name "Surgery"@en ;
    .

<http://id.worldcat.org/fast/1153364> # Toxicology
    a schema:Intangible ;
   schema:name "Toxicology"@en ;
    .

<http://id.worldcat.org/fast/976610> # Internal medicine
    a schema:Intangible ;
   schema:name "Internal medicine"@en ;
    .

<http://link.springer.com/10.1007/978-3-642-82671-9>
   rdfs:comment "from Springer" ;
   rdfs:comment "(Unlimited Concurrent Users)" ;
    .

<http://worldcat.org/isbn/9783642826719>
    a schema:ProductModel ;
   schema:isbn "3642826717" ;
   schema:isbn "9783642826719" ;
    .

<http://worldcat.org/isbn/9783642826733>
    a schema:ProductModel ;
   schema:isbn "3642826733" ;
   schema:isbn "9783642826733" ;
    .

<http://worldcat.org/issn/0080-0015> # Recent results in cancer research ;
    a bgn:PublicationSeries ;
   schema:hasPart <http://www.worldcat.org/oclc/858931023> ; # Preoperative (Neoadjuvant) Chemotherapy
   schema:issn "0080-0015" ;
   schema:name "Recent results in cancer research ;" ;
   schema:name "Recent Results in Cancer Research," ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.